Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DynamiCare App for Polysubstance Use in Methadone Maintenance
NCT05766631Phase 3Active, not recruiting
- Sponsor
- Friends Research Institute
- Start
- Jul 2023
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in opioid use disorder (OUD) and cocaine use disorder (CUD) (2 arms), sponsored by Friends Research Institute. Primary endpoint: Retention in Methadone Treatment at 48 weeks. Started Jul 2023; status: active, not recruiting.
02
Conditions
opioid use disorder (OUD)cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT05766631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05766631.